Literature DB >> 9125133

Evidence for the activation of myeloperoxidase by f-Meth-Leu-Phe prior to its release from neutrophil granulocytes.

M Zipfel1, T C Carmine, C Gerber, D Niethammer, G Bruchelt.   

Abstract

Activity and release of myeloperoxidase (MPO) was measured in heparinized whole blood samples after activation of neutrophil granulocytes by the chemoattractant N-formyl-methionyl-leucyl-phenylalanine (fMLP) using two different methods: (i) by determination of the amount of MPO released into the blood plasma using a MPO enzyme-immunoassay, and (ii) simultaneously, by measuring the remaining activity within the neutrophils by flow cytometry using the Bayer Technicon H3. Although a part of MPO was released immediately after addition of fMLP, remaining MPO activity within the neutrophils surprisingly increased during the first minutes after incubation. Subsequently, MPO activity dropped due to a continuous release of MPO. In addition to fMLP, granulocyte-macrophage colony stimulating factor (GM-CSF) enhanced MPO activity in neutrophils. These results indicate that MPO is present in resting granulocytes in an inactive or only partially active form and is activated by fMLP and GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125133     DOI: 10.1006/bbrc.1997.6257

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation.

Authors:  Valerian E Kagan; Nagarjun V Konduru; Weihong Feng; Brett L Allen; Jennifer Conroy; Yuri Volkov; Irina I Vlasova; Natalia A Belikova; Naveena Yanamala; Alexander Kapralov; Yulia Y Tyurina; Jingwen Shi; Elena R Kisin; Ashley R Murray; Jonathan Franks; Donna Stolz; Pingping Gou; Judith Klein-Seetharaman; Bengt Fadeel; Alexander Star; Anna A Shvedova
Journal:  Nat Nanotechnol       Date:  2010-04-04       Impact factor: 39.213

Review 2.  Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo.

Authors:  Gregg P Kotchey; Yong Zhao; Valerian E Kagan; Alexander Star
Journal:  Adv Drug Deliv Rev       Date:  2013-07-12       Impact factor: 15.470

3.  Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients.

Authors:  M J Leckie; S A Bryan; J Khan; A Dewar; S L Aikman; J McGrath; D A Okrongly; J F Burman; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

4.  Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytochrome b between subcellular fractions.

Authors:  Steve D Swain; Daniel W Siemsen; Laura K Nelson; Karen M Sipes; Angela J Hanson; Mark T Quinn
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

5.  Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples.

Authors:  Jörg Flemmig; Pauline Schwarz; Ingo Bäcker; Anna Leichsenring; Franziska Lange; Jürgen Arnhold
Journal:  J Vis Exp       Date:  2016-07-28       Impact factor: 1.355

Review 6.  Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.

Authors:  Amjad A Khan; Mohammed A Alsahli; Arshad H Rahmani
Journal:  Med Sci (Basel)       Date:  2018-04-18

7.  Optimization of Enzyme Essays to Enhance Reliability of Activity Measurements in Leukocyte Lysates for the Diagnosis of Metachromatic Leukodystrophy and Gangliosidoses.

Authors:  Sebastian Strobel; Naomi Hesse; Vidiyaah Santhanakumaran; Samuel Groeschel; Gernot Bruchelt; Ingeborg Krägeloh-Mann; Judith Böhringer
Journal:  Cells       Date:  2020-11-28       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.